147 related articles for article (PubMed ID: 37083308)
1. Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018.
Yang Z; Leng K; Shi G
Cancer Med; 2023 Jun; 12(12):13076-13085. PubMed ID: 37083308
[TBL] [Abstract][Full Text] [Related]
2. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
3. Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.: A Population-Based Analysis.
Afifi AM; Elmehrath AO; Ruhban IA; Saad AM; Gad MM; Al-Husseini MJ; Bekaii-Saab T; Sonbol MB
Oncologist; 2021 Sep; 26(9):733-739. PubMed ID: 34101294
[TBL] [Abstract][Full Text] [Related]
4. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
5. Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016.
Elmehrath AO; Afifi AM; Al-Husseini MJ; Saad AM; Wilson N; Shohdy KS; Pilie P; Sonbol MB; Alhalabi O
JAMA Netw Open; 2021 Aug; 4(8):e2119568. PubMed ID: 34351403
[TBL] [Abstract][Full Text] [Related]
6. Causes of death after breast cancer diagnosis: A US population-based analysis.
Afifi AM; Saad AM; Al-Husseini MJ; Elmehrath AO; Northfelt DW; Sonbol MB
Cancer; 2020 Apr; 126(7):1559-1567. PubMed ID: 31840240
[TBL] [Abstract][Full Text] [Related]
7. Analysis of competing risks of cardiovascular death in patients with hepatocellular carcinoma: A population-based study.
Cao L; Wang X; Yan Y; Ning Z; Ma L; Li Y
Medicine (Baltimore); 2023 Dec; 102(51):e36705. PubMed ID: 38134062
[TBL] [Abstract][Full Text] [Related]
8. Cause-specific mortality among patients with renal cell carcinoma in the United States from 2000 to 2018.
Elgenidy A; Awad AK; Cheema HA; Shahid A; Kacimi SEO; Aly MG; Singla N; Afifi AM; Patel HD
Urol Oncol; 2023 Apr; 41(4):209.e11-209.e20. PubMed ID: 36822993
[TBL] [Abstract][Full Text] [Related]
9. High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid.
Wang S; Ge C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10203-10215. PubMed ID: 37270459
[TBL] [Abstract][Full Text] [Related]
10. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
[TBL] [Abstract][Full Text] [Related]
11. Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis.
Jepsen P; Kraglund F; West J; Villadsen GE; Sørensen HT; Vilstrup H
J Hepatol; 2020 Nov; 73(5):1030-1036. PubMed ID: 32512015
[TBL] [Abstract][Full Text] [Related]
12. Cause of death during prostate cancer survivorship: A contemporary, US population-based analysis.
Weiner AB; Li EV; Desai AS; Press DJ; Schaeffer EM
Cancer; 2021 Aug; 127(16):2895-2904. PubMed ID: 33882145
[TBL] [Abstract][Full Text] [Related]
13. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9064):1498-504. PubMed ID: 9167458
[TBL] [Abstract][Full Text] [Related]
14. Mortality by cause for eight regions of the world: Global Burden of Disease Study.
Murray CJ; Lopez AD
Lancet; 1997 May; 349(9061):1269-76. PubMed ID: 9142060
[TBL] [Abstract][Full Text] [Related]
15. Mortality from hepatocellular and biliary cancers: changing epidemiological trends.
Nair S; Shiv Kumar K; Thuluvath PJ
Am J Gastroenterol; 2002 Jan; 97(1):167-71. PubMed ID: 11808943
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma - United States, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.
Adeniji N; Arjunan V; Prabhakar V; Mannalithara A; Ghaziani T; Ahmed A; Kwo P; Nguyen M; Melcher ML; Busuttil RW; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Burcin Taner C; Hoteit MA; Verna EC; Halazun KJ; Tevar AD; Humar A; Chapman WC; Vachharajani N; Aucejo F; Nydam TL; Markmann JF; Mobley C; Ghobrial M; Langnas AN; Carney CA; Berumen J; Schnickel GT; Sudan DL; Hong JC; Rana A; Jones CM; Fishbein TM; Agopian V; Dhanasekaran R
Liver Transpl; 2021 May; 27(5):684-698. PubMed ID: 33306254
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
Altekruse SF; McGlynn KA; Reichman ME
J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
[TBL] [Abstract][Full Text] [Related]
19. Causes of death following small cell lung cancer diagnosis: a population-based analysis.
Wu XQ; Li JY; Du WJ
BMC Pulm Med; 2022 Jul; 22(1):262. PubMed ID: 35787685
[TBL] [Abstract][Full Text] [Related]
20. Deaths from hepatocellular carcinoma are more likely to occur in medical facilities than deaths from other cancers: 2003-2018.
Truitt K; Khan SS; Gregory DL; Chuzi S; VanWagner LB
Liver Int; 2021 Jul; 41(7):1489-1493. PubMed ID: 33932082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
